IRADIMED CORP 8-K

What Happened

• IRADIMED Corporation (IRMD) filed a Form 8-K on May 1, 2026 (Item 2.02) to announce its financial results for the quarter ended March 31, 2026.
• The company issued a press release on May 1, 2026 reporting those quarterly results; the press release is furnished as Exhibit 99.1 to the 8-K.
• The report was signed by John Glenn, Chief Financial Officer, on behalf of IRADIMED.

Key Details

• Filing date: May 1, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Period covered: Quarter ended March 31, 2026 (Q1 2026).
• Press release included as Exhibit 99.1 to the 8-K.
• Cover page interactive data (Inline XBRL) included as Exhibit 104.

Why It Matters

• This 8-K notifies investors that IRADIMED has released its quarterly earnings information; investors should read the attached press release for the company’s reported revenue, net income, cash flow, and any commentary on performance or outlook.
• Because the 8-K furnishes the press release rather than amending prior SEC filings, the press release is the primary source of the new financial detail for the quarter.
• Retail investors should check the Exhibit 99.1 press release and any subsequent filings (e.g., 10-Q) for full financial statements and management discussion to assess the company’s recent performance.